CORTEF

This brand name is authorized in United States. It is also authorized in Canada, Croatia, Hong Kong SAR China, Lithuania, Tunisia.

Active ingredients

The drug CORTEF contains one active pharmaceutical ingredient (API):

1	Hydrocortisone UNII WI4X0X7BPJ - HYDROCORTISONE
	Hydrocortisone is the main glucocorticoid secreted by the adrenal cortex. Hydrocortisone is an anti-inflammatory steroid. Its anti-inflammatory action is due to reduction in the vascular component of the inflammatory response and reduction in the formation of inflammatory fluid and cellular exudates.
	Read more about Hydrocortisone

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
CORTEF Tablet	MPI, US: SPL/Old	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
H02AB09	Hydrocortisone	H Systemic hormonal preparations, excl. Sex hormones and insulins → H02 Corticosteroids for systemic use → H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN → H02AB Glucocorticoids
Discover more medicines within H02AB09

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	00030910, 00030929
HK	Department of Health Drug Office	37278
HR	Agencija za lijekove i medicinske proizvode	HR-H-281556040
LT	Valstybinė vaistų kontrolės tarnyba	1088947
TN	Direction de la Pharmacie et du Médicament	10763011
US	FDA, National Drug Code	0009-0012, 0009-0031, 0009-0044